Eye retention after proton beam radiotherapy for uveal melanoma
- PMID: 12605964
- DOI: 10.1016/s0360-3016(02)04200-1
Eye retention after proton beam radiotherapy for uveal melanoma
Abstract
Purpose: To analyze the long-term results of eye retention after conservative treatment of uveal melanoma with proton beam radiotherapy, and to analyze the causes leading to enucleation after this conservative treatment approach.
Materials and methods: This was a prospective, noncomparative, interventional, consecutive case series. A total of 2645 patients (2648 eyes) with uveal melanoma were treated between 1984 and 1999 with proton beam radiotherapy. Data were analyzed as of February 2001. Patients' age ranged from 9 to 90 years, 1284 were men, and 1361 were women. Largest tumor diameter ranged from 4 to 27.5 mm, and tumor height from 0.9 to 15.6 mm. Median follow-up time was 44 months.
Results: The overall eye retention rate at 5, 10, and 15 years after treatment was 88.9%, 86.2%, and 83.7%, respectively. In total, 218 eyes had to be enucleated. Enucleation was related to larger tumor size, mainly tumor height, proximity of posterior tumor margin to optic disc, male gender, high intraocular pressure, and large degree of retinal detachment at treatment time. After optimization of the treatment technique, the eye retention rate at 5 years was increased from 97.1% to 100% for small tumors, from 86.7% to 99.7% for medium, and from 71.1% to 89.5% for large tumors.
Conclusions: The treatment technique as used today results in excellent eye retention rates, even in less favorable cases such as large tumors and tumors located close to the optic disc. The experience and a continuous quality control program allowed us to improve the 5-year eye retention rate for all tumor sizes. These findings demonstrate the positive impact of experience and quality control-based efforts for treatment technique optimization.
Similar articles
-
Proton beam radiotherapy of uveal melanoma: Italian patients treated in Nice, France.Eur J Ophthalmol. 2009 Jul-Aug;19(4):654-60. doi: 10.1177/112067210901900421. Eur J Ophthalmol. 2009. PMID: 19551683
-
Proton therapy for uveal melanoma in 43 juvenile patients: long-term results.Ophthalmology. 2014 Apr;121(4):898-904. doi: 10.1016/j.ophtha.2013.10.032. Epub 2014 Jan 7. Ophthalmology. 2014. PMID: 24405742
-
Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.Arch Ophthalmol. 2006 Jun;124(6):838-43. doi: 10.1001/archopht.124.6.838. Arch Ophthalmol. 2006. PMID: 16769837
-
Uveal melanomas. Conservation treatment.Hematol Oncol Clin North Am. 2001 Apr;15(2):389-402. doi: 10.1016/s0889-8588(05)70219-7. Hematol Oncol Clin North Am. 2001. PMID: 11370500 Review.
-
Treatment of uveal melanoma by accelerated proton beam.Dev Ophthalmol. 2012;49:41-57. doi: 10.1159/000328257. Epub 2011 Oct 21. Dev Ophthalmol. 2012. PMID: 22042012 Review.
Cited by
-
Proton beam radiotherapy in the management of uveal melanoma: Clinical experience in Scotland.Clin Ophthalmol. 2009;3:49-55. Epub 2009 Jun 2. Clin Ophthalmol. 2009. PMID: 19668544 Free PMC article.
-
The Economic Value of MR-Imaging for Uveal Melanoma.Clin Ophthalmol. 2020 Apr 28;14:1135-1143. doi: 10.2147/OPTH.S238405. eCollection 2020. Clin Ophthalmol. 2020. PMID: 32425499 Free PMC article.
-
Early Results of Stereotactic Radiosurgery in Uveal Melanoma and Risk Factors for Radiation Retinopathy.Turk J Ophthalmol. 2020 Jun 27;50(3):156-162. doi: 10.4274/tjo.galenos.2019.78370. Turk J Ophthalmol. 2020. PMID: 32631003 Free PMC article.
-
Increased elasticity of melanoma cells after low-LET proton beam due to actin cytoskeleton rearrangements.Sci Rep. 2019 May 7;9(1):7008. doi: 10.1038/s41598-019-43453-7. Sci Rep. 2019. PMID: 31065009 Free PMC article.
-
Monte Carlo calculations and measurements of absorbed dose per monitor unit for the treatment of uveal melanoma with proton therapy.Phys Med Biol. 2008 Mar 21;53(6):1581-94. doi: 10.1088/0031-9155/53/6/005. Epub 2008 Feb 25. Phys Med Biol. 2008. PMID: 18367789 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical